Home Cart Sign in  
Chemical Structure| 890405-51-3 Chemical Structure| 890405-51-3

Structure of 3BDO
CAS No.: 890405-51-3

Chemical Structure| 890405-51-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

3BDO is a new mTOR activator which can also inhibit autophagy.

Synonyms: 3-Benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 3BDO

CAS No. :890405-51-3
Formula : C18H17NO5
M.W : 327.33
SMILES Code : O=C(O1)C(CC2=CC=CC=C2)CC1COC3=CC=CC=C3[N+]([O-])=O
Synonyms :
3-Benzyl-5-((2-nitrophenoxy)methyl)dihydrofuran-2(3H)-one
MDL No. :MFCD30187363
InChI Key :AXPZIVKEZRHGAS-UHFFFAOYSA-N
Pubchem ID :16216349

Safety of 3BDO

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of 3BDO

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bone marrow cells 60 nM 30 minutes To investigate the effect of 3BDO on the phosphorylation level of S6 in Rheb1-deficient bone marrow cells, it was found that the p-S6 level was significantly increased in Rheb1-deficient cells after 3BDO treatment. PMC6355497
LKS+ cells 60 nM 6 days To investigate the effect of 3BDO on the proportion of immature neutrophils in Rheb1-deficient LKS+ cells, it was found that the proportion of immature neutrophils was significantly reduced after 3BDO treatment. PMC6355497
Vascular Endothelial Cells (VECs) 60 μM 24 hours and 48 hours 3BDO inhibited high glucose-induced VEC autophagy and apoptosis, and alleviated cell damage by downregulating the expression of CA7-4. PMC6984615
AML cells 30 nM/ml 48 hours 3BDO increased the phosphorylation of S6 and 4E-BP1 in Rheb1Δ/ΔGFP+ cells and significantly reduced the apoptosis of Rheb1Δ/ΔGFP+ cells. PMC4830070

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.06mL

0.61mL

0.31mL

15.28mL

3.06mL

1.53mL

30.55mL

6.11mL

3.06mL

References

 

Historical Records

Categories